The future role of molecular and cell biology in medical practice in the tropical countries

British Medical Bulletin

Volumn 54, Issue 2, 1998, Pages 489-501

  Weatherall, David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; MEDICAL PRACTICE; MOLECULAR BIOLOGY; POPULATION DYNAMICS; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW; TROPICAL MEDICINE;

EID: 0031856477     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011703     Document Type: Review

References (33)

1. Ad Hoc Committee on Health Research Relating to Future Intervention Options. Investing in Health Research and Development. Geneva: World Health Organization, 1996; (Document TDR/Gen/96.1 )
2. Zimmet P. The challenge of diabetes.In: Fischer EP. Möller G. (eds) The Medical Challenge. Complex Traits, Zürich: Piper, 1997; 55-110
3. Raskó I, Downes CS. Molecular Biology and Human Genetic Disorders. Genes in Medicine, London: Chapman & Hall, 1995
4. Strachan, The human genome. Read AP, Brown T. (eds) Medical Perspectives Series. Oxford: BIOS Scientific; 1992; 160
5. Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet AL, Sly WS, Valle D. (eds) The Metabolic Basis of Inherited Disease. New York: McGraw Hill, 1995; 3417-84
6. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997; 337: 762-9
7. Weatherall DJ, Clegg JB. Thalassemia - a global public health problem. Nat Med 1996; 2: 847-9
8. Cao A, Rosatelli MC. Screening and prenatal diagnosis of the haemoglobinopathies. Clin Haematol 1993; 6: 263-86
9. Flint J. Harding RM. Boyce AJ. Clegg JB. The population genetics of the haemoglobinopathies. Clin Haematol 1993; 6: 215-62
10. +-thalassaemia protects children against disease due to malaria and other infections. Proc Natl Acad Sci VSA 1997; 94: 14736-41
11. Williams TN. Maitland K, Bennett S et al High incidence of malaria in α-thalasssaemic children. Nature 1996; 383: 522-5
12. Maitland K, Williams TN, Newbold CI. Plasmodium vivax and P. falciparum: biological interactions and the possibility of cross-species immunity. Parasitol Today 1997; 13: 227-31
13. Ruwende C, Khoo RW, Snow RW et al. Natural selection of hemi- and heterozygotes for glucose-6-phosphate-dehydrogenase deficiency by resistance to severe malaria. Nature 1995; 376: 246-9
14. Tournamille C, Colin Y, Cartron JP, Kim CLV. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duff-negative individuals. Nat Genet 1995; 10: 224-8
15. Miller LH. Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans Proc Natl Acad Sci USA 1994; 91: 2415-9
16. Hill AVS, Allsopp CEM, Kwiatkowski D et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600
17. Hill AVS, Elvin J, Willis A et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360: 434-9
18. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promotor region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-11
19. Fernandez-Reyes D, Craig A, Kyes SA et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet 1997; 6: 1357-60
20. Hill AVS. Genetics of infectious disease resistance. Curr Opin Genet Dev 1996; 6: 348-53
21. Weatherall DJ, Clegg JB, Kwiatkowski D. The role of genomics in studying genetic susceptibility to infectious disease. Genome Res 1997; 7: 967-73
22. Almari A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194
23. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus in The Gambia. NEngl J Med 1995; 332: 1065-9
24. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174: 878-80
25. Roy S, McGuire W, Mascie-Taylor CGN et al. TNF promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997; 176: 530-2
26. Conway DJ, Holland MJ, Bailey RL et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infect Immun 1997; 65: 1003-6
27. Madsen HO, Garred P, Kurtzhais JA et al. A new frequent allde is the missing link in the structural polymorphism of the human mannan-binding protein Immunogenetics 1994; 40: 37-4
28. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human secretor blood group alpha(l,2}fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 1995; 270: 4640-9
29. Liu R, Paxton WA, Choe S et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Co-receptor account for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-77
30. Marquet S, Abel L, Hillaire D et al. Genetic localisation of a locus controlling the intensity of infection by Schistoma mansoni on chromosome 5q31-q35. Nat Genet 1996; 14: 181-4
31. Strauss EJ, Falkow S. Microbial pathogenesis: genomics and beyond. Science 1997; 276: 707-11
32. Moxon ER, Thaler DS. The tinkerer's evolving tool-box. Nature 1997; 387: 659-62
33. Hassen DE, Whitton JL. DNA immunization. Trends Microbiol 1996; 4: 307-12